Shanghai-based InventisBio, a biotech company, has secured $19 million in Series B financing. OrbiMed Asia Partners led the round with participation from Lilly Asia Ventures.
Source: Press Release
Shanghai-based InventisBio, a biotech company, has secured $19 million in Series B financing. OrbiMed Asia Partners led the round with participation from Lilly Asia Ventures.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: